| References |
|
|
Abe K,
Endo Y,
Nakazawa N et al.
(2009)
Unique phenotypes of C1s deficiency and abnormality caused by two compound heterozygosities in a Japanese family.
Journal of Immunology
182:
1681–1688.
|
|
|
Biesma DH,
Hannema AJ,
van Velzen-Blad H et al.
(2001)
A family with complement factor D deficiency.
Journal of Clinical Investigation
108:
233–240.
|
|
|
Bishof NA,
Welch TR and
Beischel LS
(1990)
C4B deficiency: a risk factor for bacteremia with encapsulated organisms.
Journal of Infectious Diseases
162:
248–250.
|
|
|
Blom AM,
Bergstrom F,
Edey M et al.
(2008)
A novel non-synonymous polymorphism (p.Arg240His) in C4b-binding protein is associated with atypical hemolytic uremic syndrome and leads to impaired alternative pathway cofactor activity.
Journal of Immunology
180:
6385–6391.
|
|
|
Botto M,
Dell'Agnola C,
Bygrave AE et al.
(1998)
Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies.
Nature Genetics
19:
56–59.
|
|
|
Caprioli J,
Noris M,
Brioschi S et al.
(2006)
Genetics of HUS: the impact of MCP, CFH, and IF mutations on clinical presentation, response to treatment, and outcome.
Blood
108:
1267–1279.
|
|
|
Carroll MC
(2004)
The complement system in regulation of adaptive immunity.
Nature Immunology
5:
981–986.
|
|
|
Dahl M,
Tybjaerg-Hansen A,
Schnohr P and
Nordestgaard BG
(2004)
A population-based study of morbidity and mortality in mannose-binding lectin deficiency.
Journal of Experimental Medicine
199:
1391–1399.
|
|
|
Dragon-Durey MA,
Quartier P,
Fremeaux-Bacchi V et al.
(2001)
Molecular basis of a selective C1s deficiency associated with early onset multiple autoimmune diseases.
Journal of Immunology
166:
7612–7616.
|
|
|
Fijen CA,
van den Bogaard R,
Schipper M et al.
(1999)
Properdin deficiency: molecular basis and disease association.
Molecular Immunology
36:
863–867.
|
|
|
Fremeaux-Bacchi V,
Miller EC,
Liszewski MK et al.
(2008)
Mutations in complement C3 predispose to development of atypical hemolytic uremic syndrome.
Blood
112:
4948–4952.
|
|
|
Fremeaux-Bacchi V,
Moulton EA,
Kavanagh D et al.
(2006)
Genetic and functional analyses of membrane cofactor protein (CD46) mutations in atypical hemolytic uremic syndrome.
Journal of American Society of Nephrology
17:
2017–2025.
|
|
|
Ghannam A,
Pernollet M,
Fauquert JL et al.
(2008)
Human C3 deficiency associated with impairments in dendritic cell differentiation, memory B cells, and regulatory T cells.
Journal of Immunology
181:
5158–5166.
|
|
|
Goicoechea de Jorge E,
Harris CL,
Esparza-Gordillo J et al.
(2007)
Gain-of-function mutations in complement factor B are associated with atypical hemolytic uremic syndrome.
Proceedings of the National Academy of Sciences of the USA
104:
240–245.
|
|
|
Gold B,
Merriam JE,
Zernant J et al.
(2006)
Variation in factor B (BF) and complement component 2 (C2) genes is associated with age-related macular degeneration.
Nature Genetics
38:
458–462.
|
|
|
Hageman GS,
Anderson DH,
Johnson LV et al.
(2005)
A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration.
Procedings of the National Academy of Sciences of the USA
102:
7227–7232.
|
|
|
Haines JL,
Hauser MA,
Schmidt S et al.
(2005)
Complement factor H variant increases the risk of age-related macular degeneration.
Science
308:
419–421.
|
|
|
Jokiranta TS,
Zipfel PF,
Fremeaux-Bacchi V et al.
(2007)
Where next with atypical hemolytic uremic syndrome?
Molecular Immunology
44:
3889–3900.
|
|
|
Jonsson G,
Sjoholm AG,
Truedsson L et al.
(2007)
Rheumatological manifestations, organ damage and autoimmunity in hereditary C2 deficiency.
Rheumatology (Oxford)
46:
1133–1139.
|
|
|
Jonsson G,
Truedsson L,
Sturfelt G et al.
(2005)
Hereditary C2 deficiency in Sweden: frequent occurrence of invasive infection, atherosclerosis, and rheumatic disease.
Medicine (Baltimore)
84:
23–34.
|
|
|
Jozsi M,
Strobel S,
Dahse HM et al.
(2007)
Anti factor H autoantibodies block C-terminal recognition function of factor H in hemolytic uremic syndrome.
Blood
110:
1516–1518.
|
|
|
Kavanagh D,
Goodship TH and
Richards A
(2006)
Atypical haemolytic uraemic syndrome.
British Medical Bulletin
77–78:
5–22.
|
|
|
Kavanagh D,
Richards A,
Noris M et al.
(2008)
Characterization of mutations in complement factor I (CFI) associated with hemolytic uremic syndrome.
Molecular Immunology
45:
95–105.
|
|
|
Khajoee V,
Ihara K,
Kira R et al.
(2003)
Founder effect of the C9 R95X mutation in orientals.
Human Genetics
112:
244–248.
|
|
|
Kojima T,
Horiuchi T,
Nishizaka H et al.
(1998)
Genetic basis of human complement C8 alpha-gamma deficiency.
Journal of Immunology
161:
3762–3766.
|
|
|
Kotnik V,
Luznik-Bufon T,
Schneider PM and
Kirschfink M
(1997)
Molecular, genetic, and functional analysis of homozygous C8 beta-chain deficiency in two siblings.
Immunopharmacology
38:
215–221.
|
|
|
Manuelian T,
Hellwage J,
Meri S et al.
(2003)
Mutations in factor H reduce binding affinity to C3b and heparin and surface attachment to endothelial cells in hemolytic uremic syndrome.
Journal of Clinical Investigation
111:
1181–1190.
|
|
|
Nilsson SC,
Trouw LA,
Renault N et al.
(2009)
Genetic, molecular and functional analyses of complement factor I deficiency.
European Journal of Immunology
39:
310–323.
|
|
|
Orren A,
Potter PC,
Cooper RC and
du Toit E
(1987)
Deficiency of the sixth component of complement and susceptibility to Neisseria meningitidis infections: studies in 10 families and five isolated cases.
Immunology
62:
249–253.
|
|
|
Parker C
(2009)
Eculizumab for paroxysmal nocturnal haemoglobinuria.
Lancet
373:
759–767.
|
|
|
Petersen BH,
Lee TJ,
Snyderman R and
Brooks GF
(1979)
Neisseria meningitidis and Neisseria gonorrhoeae bacteremia associated with C6, C7, or C8 deficiency.
Annals of Internal Medicine
90:
917–920.
|
|
|
Pickering MC,
Botto M,
Taylor PR,
Lachmann PJ and
Walport MJ
(2000)
Systemic lupus erythematosus, complement deficiency, and apoptosis.
Advances in Immunology
76:
227–324.
|
|
|
Platonov AE,
Beloborodov VB and
Vershinina IV
(1993)
Meningococcal disease in patients with late complement component deficiency: studies in the U.S.S.R.
Medicine (Baltimore)
72:
374–392.
|
|
|
Richards A,
Kathryn Liszewski M,
Kavanagh D et al.
(2007a)
Implications of the initial mutations in membrane cofactor protein (MCP; CD46) leading to atypical hemolytic uremic syndrome.
Molecular Immunology
44:
111–122.
|
|
|
Richards A,
Kavanagh D and
Atkinson JP
(2007b)
Inherited complement regulatory protein deficiency predisposes to human disease in acute injury and chronic inflammation states. The examples of vascular damage in atypical hemolytic uremic syndrome and debris accumulation in age-related macular degeneration.
Advances in Immunology
96:
141–177.
|
|
|
Richardson AJ,
Islam FM,
Guymer RH and
Baird PN
(2009)
Analysis of rare variants in the complement component 2 (C2) and factor B (BF) genes refine association for age-related macular degeneration (AMD).
Investigative Ophthalmology & Visual Science
50:
540–543.
|
|
|
Rosenfeld SI,
Kelly ME and
Leddy JP
(1976)
Hereditary deficiency of the fifth component of complement in man. I. Clinical, immunochemical, and family studies.
Journal of Clinical Investigation
57:
1626–1634.
|
|
|
Saucedo L,
Ackermann L,
Platonov AE et al.
(1995)
Delineation of additional genetic bases for C8 beta deficiency. Prevalence of null alleles and predominance of C–>T transition in their genesis.
Journal of Immunology
155:
5022–5028.
|
|
|
Selander B,
Martensson U,
Weintraub A et al.
(2006)
Mannan-binding lectin activates C3 and the alternative complement pathway without involvement of C2.
Journal of Clinical Investigation
116:
1425–1434.
|
|
|
Sjöberg AP,
Trouw LA,
Clark SJ et al.
(2007)
The factor H variant associated with age-related macular degeneration (His-384) and the non-disease-associated form bind differentially to C-reactive protein, fibromodulin, DNA, and necrotic cells.
Journal of Biological Chemistry
282:
10894–10900.
|
|
|
Sjoholm AG,
Jonsson G,
Braconier JH,
Sturfelt G and
Truedsson L
(2006)
Complement deficiency and disease: an update.
Molecular Immunology
43:
78–85.
|
|
|
Spitzer D,
Mitchell LM,
Atkinson JP and
Hourcade DE
(2007)
Properdin can initiate complement activation by binding specific target surfaces and providing a platform for de novo convertase assembly.
Journal of Immunology
179:
2600–2608.
|
|
|
Sprong T,
Roos D,
Weemaes C et al.
(2006)
Deficient alternative complement pathway activation due to factor D deficiency by 2 novel mutations in the complement factor D gene in a family with meningococcal infections.
Blood
107:
4865–4870.
|
|
|
Thiel S,
Frederiksen PD and
Jensenius JC
(2006)
Clinical manifestations of mannan-binding lectin deficiency.
Molecualr Immunology
43:
86–96.
|
|
|
Trapp RG,
Fletcher M,
Forristal J and
West CD
(1987)
C4 binding protein deficiency in a patient with atypical Behcet's disease.
Journal of Rheumatology
14:
135–138.
|
|
|
Vyse TJ,
Morley BJ,
Bartok I et al.
(1996)
The molecular basis of hereditary complement factor I deficiency.
Journal of Clinical Investigation
97:
925–933.
|
|
|
Wulffraat NM,
Sanders EA,
Fijen CA et al.
(1994)
Deficiency of the beta subunit of the eighth component of complement presenting as arthritis and exanthem.
Arthritis and Rheumatism
37:
1704–1706.
|
|
|
Wurzner R,
Hobart MJ,
Fernie BA et al.
(1995)
Molecular basis of subtotal complement C6 deficiency. A carboxy-terminally truncated but functionally active C6.
Journal of Clinical Investigation
95:
1877–1883.
|
|
|
Yang Y,
Chung EK,
Zhou B et al.
(2004)
The intricate role of complement component C4 in human systemic lupus erythematosus.
Current Directions in Autoimmunity
7:
98–132.
|
| Further Reading |
|
|
Colten HR and
Rosen FS
(1992)
Complement deficiencies.
Annual Review of Immunology
10:
809–834.
|
|
|
Jozsi M and
Zipfel PF
(2008)
Factor H family proteins and human diseases.
Trends in Immunology
29:
380–387.
|
|
|
Kolble K and
Reid KBM
(1993)
Genetic deficiencies of the complement system associated with disease – early components.
International Reviews of Immunology
10:
17–36.
|
|
|
Lokki ML and
Colten HR
(1995)
Genetic deficiencies of complement.
Annals of Medicine
27:
451–459.
|
|
|
Tedesco F
(2008)
Inherited complement deficiencies and bacterial infections.
Vaccine
26S:
13–18.
|
|
|
Truedsson L,
Bengtsson AA and
Sturfelt G
(2007)
Complement deficiencies and systemic lupus erythematosus.
Autoimmunity
40:
560–566.
|
|
|
Unsworth DJ
(2008)
Complement deficiency and disease.
Journal of Clinical Pathology
61:
1013–1017.
|
|
|
book
Winkelstein JA,
Sullivan K and
Colten H
(1995)
"Genetically determined disorders of the complement system".
In: Schriver CR,
Beaudet AL,
Sly WS and
Valle D (eds)
The Metabolic Basis for Inherited Disease,
7th edn.
New York: McGraw-Hill.
|
|
|
Wurzner R
(2003)
Deficiencies of the complement MAC II gene cluster (C6, C7, C9): is subtotal C6 deficiency of particular evolutionary benefit?
Clinical and Experimental Immunology
133:
156–159.
|
